Efficient mutation screening for cervical cancers from circulating tumor DNA in blood

BACKGROUND: Early diagnosis and continuous monitoring are necessary for an efficient management of cervical cancers (CC). Liquid biopsy, such as detecting circulating tumor DNA (ctDNA) from blood, is a simple, non-invasive method for testing and monitoring cancer markers. However, tumor-specific alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sun-Young, Chae, Dong-Kyu, Lee, Sung-Hun, Lim, Yohan, An, Jahyun, Chae, Chang Hoon, Kim, Byung Chul, Bhak, Jong, Bolser, Dan, Cho, Dong-Hyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385901/
https://www.ncbi.nlm.nih.gov/pubmed/32718341
http://dx.doi.org/10.1186/s12885-020-07161-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385901/
https://www.ncbi.nlm.nih.gov/pubmed/32718341
http://dx.doi.org/10.1186/s12885-020-07161-0

Ejemplares similares